Cargando…

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage

Detalles Bibliográficos
Autores principales:	Schneider, AS, Voirol, P, Perez, M, Schoettker, P, Wasserfallen, JB, Angelillo-Scherrer, A, Chiolero, R, Cotting, J, Eggimann, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084314/ http://dx.doi.org/10.1186/cc7592

Ejemplares similares

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Five-year evolution of drug prescribing in a university adult intensive care unit
por: Voirol, P, et al.
Publicado: (2010)

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Successful hemostasis in refractory alveolar hemorrhage using low-dose recombinant activated factor VII
por: Selickman, John, et al.
Publicado: (2022)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
por: Aggarwal, Anita, et al.
Publicado: (2004)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery
por: Barua, Anupama, et al.
Publicado: (2011)

Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis
por: Mandal, S. K., et al.
Publicado: (2012)

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
por: Heslet, Lars, et al.
Publicado: (2006)

Life-threatening hemorrhage in neonates and children: treatment with activated recombinant factor VII
por: Fischer, D, et al.
Publicado: (2003)

Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side
por: van Veen, E. J. W., et al.
Publicado: (2007)

Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage
por: Park, Soon Chang, et al.
Publicado: (2017)

Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
por: Ansari, Amir M., et al.
Publicado: (2021)

Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes
por: Emlet, Lillian L, et al.
Publicado: (2006)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Recombinant Activated Factor VIIa Treatment for Refractory Hemorrhage in Infants
por: Dang, Chi N, et al.
Publicado: (2010)

Adequacy of Hemostatic Resuscitation Improves Therapeutic Efficacy of Recombinant Activated Factor VII and Reduces Reexploration Rate for Bleeding in Postoperative Cardiac Surgery Patients with Refractory Hemorrhage
por: Feih, Joel T, et al.
Publicado: (2019)

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis
por: Khoulani, Dania, et al.
Publicado: (2014)

Perioperative administration of recombinant activated factor VII in a Glanzmannʼs thrombasthenia patient with platelet refractoriness: case report
por: Bisinotto, Flora Margarida Barra, et al.
Publicado: (2021)

Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience
por: Shah, Nurfatin Mohd, et al.
Publicado: (2018)

Study of Early Elevated Gas6 Plasma Level as a Predictor of Mortality in a Prospective Cohort of Patients with Sepsis
por: Stalder, Grégoire, et al.
Publicado: (2016)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer
por: Esper, Raúl Carrillo, et al.
Publicado: (2014)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Risk factors for hypertriglyceridemia in the intensive care unit: an exploratory study
por: Devaud, JC, et al.
Publicado: (2010)

High Dose, Prolonged Epsilon Aminocaproic Acid Infusion, and Recombinant Factor VII for Massive Postoperative Retroperitoneal Hemorrhage following Splenectomy
por: Lee, Alex T., et al.
Publicado: (2016)

Haemodynamic effects of a fluid challenge with hydroxylethyl starch 130/0.4 (Voluven(®)) in patients suffering from symptomatic vasospasm after subarachnoid haemorrhage
por: Van Tulder, L, et al.
Publicado: (2008)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
por: Poon, Man-Chiu
Publicado: (2021)

Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use
por: Bomken, Charlotte, et al.
Publicado: (2009)

Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
por: Rajpurkar, Madhvi, et al.
Publicado: (2018)

Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding
por: Klitgaard, Thomas, et al.
Publicado: (2006)

Recombinant activated factor VII in cardiac surgery – first, do no harm
por: Warren, Oliver J, et al.
Publicado: (2007)

Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma
por: Pusateri, Anthony E, et al.
Publicado: (2005)

Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
por: AlGahtani, Farjah H., et al.
Publicado: (2010)

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Prophylactic administration of recombinant activated factor VII in coronary revascularization surgery
por: Abdel-Meguid, Mohamed Essam
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_pglfm3j2tmk031fgtn0hu8t5uv